Lung fibrosis, premature graying, and macrocytosis
School of Medicine, The University of Queensland, Brisbane, Australia.American Journal of Respiratory and Critical Care Medicine (Impact Factor: 11.99). 09/2012; 186(5):e8-9. DOI: 10.1164/rccm.201112-2175IM
- [Show abstract] [Hide abstract]
ABSTRACT: This perspective highlights some evidence that have hitherto been neglected especially because they may not have been sufficiently explicited in the clinical respiratory medicine literature. Idiopathic pulmonary fibrosis (IPF) has appeared only in the second half of the twentieth century and may be, as lung cancer and chronic obstructive pulmonary disease, a direct consequence of the cigarette smoking epidemics. It is a disease of lung aging, with most affected patients being older than 70 years. The relationship between lung aging and pulmonary fibrosis is further illustrated in the bleomycin mouse model, in which older males develop more fibrosis than young female mice.An earlier diagnosis of IPF is a prerequisite for significant progress to be made in the long-term outcome and prognosis.The present authors consider that only two different yet complementary and realistic approaches could lead to diagnosing IPF earlier and possibly to allowing a more efficient disease management: (i) investigating any patients with early Velcro crackles at lung auscultation through proactive education of - and commitment from - primary care physicians; (ii) and using current large-scale lung cancer screening strategies with low-dose high-resolution computed tomography in smokers for the detection of subclinical interstitial lung disease and especially early IPF.European Respiratory Journal 04/2013; 42(4). DOI:10.1183/09031936.00027913 · 7.13 Impact Factor
Article: Telomeres in lung disease[Show abstract] [Hide abstract]
ABSTRACT: Telomeres are DNA-protein structures that cap the ends of chromosomes; telomerase is the enzyme that ensures their integrity. Telomere biology has recently been implicated in the pathogenesis of a variety of lung diseases, including idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease/emphysema, and lung cancer. This review highlights recent discoveries pertaining to the role of telomere biology in lung disease.04/2013; 162(6). DOI:10.1016/j.trsl.2013.04.001
- American Journal of Respiratory and Critical Care Medicine 07/2013; 188(2):252-3. DOI:10.1164/rccm.201301-0192LE · 11.99 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.